Growth hormone-releasing hormone antagonists counteract hydrogen peroxide – induced paracellular hyperpermeability in endothelial cells

An antagonist of growth hormone-releasing hormone protects against LPS-induced increase of bronchoalveolar lavage fluid protein concentration

(2022) Mohammad S. Akhter et al.   INFLAMMATION RESEARCH

Unfolded protein response in endothelial injury

(2022) Nektarios Barabutis   CELL CYCLE

Molecular mechanisms underlying the heterogeneous barrier responses of two primary endothelial cell types to sphingosine-1-phosphate

(2022) Alec T. Salminen et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Activating transcription factor 6 protects against endothelial barrier dysfunction

(2022) Khadeja-Tul Kubra et al.   CELLULAR SIGNALLING

Actin remodeling mediates ROS production and JNK activation to drive apoptosis-induced proliferation

(2022) Luchi Farrell et al.   PLoS Genetics

Suppression of reactive oxygen species in endothelial cells by an antagonist of growth hormone‐releasing hormone

(2021) Mohammad S. Akhter et al.   JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY

Induction of the NEK family of kinases in the lungs of mice subjected to cecal ligation and puncture model of sepsis

(2021) Mohammad A. Uddin et al.   Tissue Barriers

Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity

(2021) Renzhi Cai et al.   PEPTIDES

P53 in RhoA Regulation

(2020) Nektarios Barabutis   Cytoskeleton

Regulation of lung endothelial permeability by NEK kinases

(2020) Nektarios Barabutis   IUBMB LIFE

Unfolded Protein Response in Lung Health and Disease

(2020) Nektarios Barabutis   Frontiers in Medicine

P53 in acute respiratory distress syndrome

(2020) Nektarios Barabutis   CELLULAR AND MOLECULAR LIFE SCIENCES

Unfolded protein response in cardiovascular disease

(2020) Khadeja-Tul Kubra et al.   CELLULAR SIGNALLING

Pharmacologic ATF6 activation confers global protection in widespread disease models by reprograming cellular proteostasis

(2019) Erik A. Blackwood et al.   Nature Communications

Hsp90 inhibitors induce the unfolded protein response in bovine and mice lung cells

(2019) Khadeja-Tul Kubra et al.   CELLULAR SIGNALLING

P53 Regulates the Redox Status of Lung Endothelial Cells

(2019) Mohammad S. Akhter et al.   INFLAMMATION

Wild-type p53 enhances endothelial barrier function by mediating RAC1 signalling and RhoA inhibition

(2018) Nektarios Barabutis et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Neuronal Nitric Oxide Synthase in Vascular Physiology and Diseases

(2016) Eduardo D. Costa et al.   Frontiers in Physiology

Reactive Oxygen Species in Inflammation and Tissue Injury

(2013) Manish Mittal et al.   ANTIOXIDANTS & REDOX SIGNALING

Mechanisms of inhibition of human benign prostatic hyperplasia in vitro by the luteinizing hormone-releasing hormone antagonist cetrorelix

(2010) Agnieszka Siejka et al.   BJU INTERNATIONAL

Growth hormone releasing hormone induces the expression of nitric oxide synthase

(2010) Nektarios Barabutis et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Antagonists of growth hormone-releasing hormone inhibit the proliferation of human benign prostatic hyperplasia cells

(2010) Agnieszka Siejka et al.   PROSTATE

Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53

(2009) Stefano Salvioli et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line

(2008) N. Barabutis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer

(2007) Andrew V Schally et al.   Nature clinical practice. Endocrinology & metabolism